Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd., a prominent developer of regenerative implantable medical devices in China, has announced the successful completion of its Series C financing round, raising RMB 300 million (USD 40.9 million). The round was led by the SCGC Manufacturing Industry Transformation and Upgrading to New Materials Fund. The funds raised will be directed towards the commercial promotion of novel medical devices, the conduct of clinical studies, and the implementation of a global strategy.
Company Background and Achievements
Established in March 2017, Neo Modulus is a joint venture founded by a team of Chinese and German scientists, spearheaded by members of the National Major Talent Program. The company has made significant strides in the medical device sector, holding three Category III medical licenses. Its diverse product portfolio spans multiple medical fields, including dentistry, ophthalmology, reproductive medicine, sports medicine, otolaryngology, and surgery. This broad range of applications underscores Neo Modulus’ commitment to innovation and excellence in regenerative medical technology.-Fineline Info & Tech
Leave a Reply